Genea Group Media Releases May 2021

May 2021

Hope for families as Government delivers

Posted: 11/05/2021 12:56:13 PM
After more than a decade of lobbying the Government to provide funding for preimplantation genetic diagnosis (PGD) the Morrison Government has announced $95.9 million will be allocated to new tests on the MBS for genetic testing of embryos for specific chromosomal abnormalities.
Read more

Media Contact

Alexandra Suvajac
Media Enquiries
M: 0436 489 199
E: alex@healthcareprgirl.com

 

About Genea

Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 35 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. 

News Archives

LinkedIn Instagram
Genea shares patient stories to help people experiencing infertility to understand that they are not alone. Hearing about other people experiencing the same challenges is a powerful way to break the isolation and stigma that often surrounds infertility. We share these stories with the intent to inform, educate and comfort and have no intention to create unreasonable expectations of beneficial treatment. Similarly, we have no intention for our community to believe the stories told are the outcomes that would be achieved for every patient. Read more about our policy on sharing personal stories.
Home Privacy Policy Disclaimer Genea Group
© Copyright 2023 Genea Limited. ABN 82 002 844 448